← All companies
INDV
Indivior Pharmaceuticals, Inc.
$37.37
-2.64 -6.60%
Key statistics
from XBRL data in SEC filingsMarket cap
$4.41B
Revenue (TTM)
$1.33B
Net income (TTM)
$356M
EPS (TTM)
$2.79
P/E ratio
13.4
Dividend yield
—
Free cash flow
-$93.0M
Cash
$222M
Total assets
$1.23B
Gross margin
82.2%
52-week range
$21.16 – $42.81
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 3, 2026
8-K
Regulation FD disclosure
Aug 3, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 3, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Aug 3, 2026
8-K
Director or officer change; Shareholder vote results
May 15, 2026
8-K
Regulation FD disclosure; Other events
May 4, 2026
10-Q
Quarter ended 2026-03-31
Apr 30, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 30, 2026
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity
Mar 17, 2026
8-K
Other events
Mar 13, 2026
8-K
Other events
Mar 12, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 26, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Regulation FD disclosure; Other events
Jan 26, 2026
8-K
Regulation FD disclosure
Jan 8, 2026
8-K
Regulation FD disclosure
Dec 22, 2025
8-K
Director or officer change
Dec 18, 2025
8-K
Amended charter or bylaws; Shareholder vote results
Dec 15, 2025
8-K
Terminated a material agreement; Regulation FD disclosure
Nov 20, 2025
8-K
Regulation FD disclosure
Nov 14, 2025
8-K/A
Exit or disposal costs
Oct 30, 2025
10-Q
Quarter ended 2025-09-30
Oct 30, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Oct 30, 2025
8-K
Regulation FD disclosure
Oct 1, 2025
8-K
Exit or disposal costs
Aug 26, 2025
8-K
Director or officer change
Aug 22, 2025
8-K/A
Director or officer change
Aug 4, 2025
10-Q
Quarter ended 2025-06-30
Jul 31, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jul 31, 2025
8-K
Regulation FD disclosure
Jun 30, 2025
8-K
Director or officer change; Other events
Jun 24, 2025
8-K
Regulation FD disclosure
Jun 2, 2025
8-K
Other events
Jun 2, 2025
8-K/A
Shareholder vote results
May 12, 2025
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure
May 8, 2025
10-Q
Quarter ended 2025-03-31
May 1, 2025
8-K
Results of operations (earnings release)
Apr 24, 2025
8-K
Regulation FD disclosure
Mar 27, 2025
8-K
Entered a material agreement; Director or officer change
Mar 4, 2025
10-K
Fiscal year ended 2024-12-31
Mar 3, 2025